Ten Berg, Jurrien M <br/><br/>
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial).  [electronic resource] 

 -  The American journal of cardiology  03 2020 
 - 735-743 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1913 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2019.11.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--therapeutic use<br/>Aspirin--therapeutic use<br/>Atrial Fibrillation--complications<br/>Clopidogrel--therapeutic use<br/>Coronary Artery Disease--therapy<br/>Dabigatran--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Revascularization--statistics & numerical data<br/>Percutaneous Coronary Intervention<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Proportional Hazards Models<br/>Stroke--etiology<br/>Thromboembolism--epidemiology<br/>Ticagrelor--therapeutic use<br/>Treatment Outcome<br/>Warfarin--therapeutic use